| 6YQN: reference: Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma., Zhang X, Zegar T, Weiser T, Hamdan FH, Berger BT, Lucas R, Balourdas DI, Ladigan S, Cheung PF, Liffers ST, Trajkovic-Arsic M, Scheffler B, Joerger AC, Hahn SA, Johnsen SA, Knapp S, Siveke JT, Int J Cancer. 2020 Nov 15;147(10):2847-2861. doi: 10.1002/ijc.33137. Epub 2020, Jun 29. PMID: 32599645 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).